Testing outside of the National Bowel and Breast Cancer Screening Programs in Queensland, Australia

被引:0
|
作者
Fletcher, Sabine [1 ]
Goodwin, Belinda C. [1 ,2 ]
机构
[1] Canc Council Queensland, Hlth Syst & Behav Res, Fortitude Valley, Qld, Australia
[2] Univ Southern Queensland, Ctr Hlth Res, Springfield, Qld, Australia
关键词
Breast cancer; bowel cancer; screening; population screening programs; reporting;
D O I
10.1177/09691413241256595
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Setting: Bowel and breast cancer testing outside of the national programs is not routinely recorded in Australia, limiting our ability to monitor and estimate true screening coverage. Objective: This study makes preliminary estimates of the proportion of eligible participants who test for bowel and breast cancer outside of national programs using a large convenience sample of 31,065 cancer risk calculator respondents. Methods: Logistic regression was applied to assess difference in cancer testing both within and outside respective programs between demographic groups. Results: Almost one-third (9456 respondents) were aged between 50 and 74 years and eligible to participate in the National Bowel Cancer Screening Program (NBCSP) with 8073 female respondents additionally qualifying for the national BreastScreen program. Out of 4166 respondents who reported not to participate in the NBCSP, over 2000 (48.4%) reported 'screening' outside the NBCSP. For breast cancer the rate of self-reported screening outside BreastScreen was even higher, with 2442 (73.8%) of 3308 respondents who did not participate in BreastScreen reporting undergoing testing elsewhere. Interestingly, outer regional or remote residence was associated with lower participation within the NBCSP (OR = 0.92; p = 0.05) and higher testing outside of BreastScreen (OR = 1.21; p < 0.05) screening programs. Conclusion: Findings provide preliminary support for the need to better understand the volume of cancer testing taking place outside the national programs and to address reporting gaps within the health system.
引用
收藏
页码:44 / 47
页数:4
相关论文
共 50 条
  • [41] Time to participation in the National Bowel Cancer Screening Program
    Pereira, M.
    Sultana, F.
    Mckenzie, N.
    Burnham, A.
    Gertig, D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 36 - 36
  • [42] Impending or pending? The national bowel cancer screening programme
    Atkin, VS
    BRITISH MEDICAL JOURNAL, 2006, 332 (7544): : 742 - 742A
  • [43] The National Bowel Cancer Screening Program Consequences for practice
    Bobridge, Amanda
    Cole, Steve
    Schoeman, Mark
    Lewis, Helen
    Bampton, Peter
    Young, Graeme
    AUSTRALIAN FAMILY PHYSICIAN, 2013, 42 (03) : 141 - 145
  • [44] Optimising the expansion of the National Bowel Cancer Screening Program
    Cenin, Dayna R.
    St John, D. James B.
    Ledger, Melissa J. N.
    Slevin, Terry
    Lansdorp-Vogelaar, Iris
    MEDICAL JOURNAL OF AUSTRALIA, 2014, 201 (08) : 456 - 461
  • [45] England to start national bowel cancer screening progrannne
    Mayor, S
    BRITISH MEDICAL JOURNAL, 2004, 329 (7474): : 1061 - 1061
  • [46] Consumer choice and the National Bowel Cancer Screening Program
    Salkeld, Glenn P.
    Young, Jane M.
    Solomon, Michael J.
    MEDICAL JOURNAL OF AUSTRALIA, 2006, 184 (11) : 541 - 542
  • [47] National screening programs for cervical cancer in Asian countries
    Aoki, Eiko Saitoh
    Yin, Rutie
    Li, Kemin
    Bhatla, Neerja
    Singhal, Seema
    Ocviyanti, Dwiana
    Saika, Kumiko
    Suh, Mina
    Kim, Miseon
    Termrungruanglert, Wichai
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (03)
  • [48] BREAST-CANCER SCREENING - VIEW FROM OUTSIDE CONTROVERSY
    THIER, SO
    NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (19): : 1063 - 1065
  • [49] Earlier diagnosis of breast cancer outside of a screening programme REPLY
    Flowers, Chris I.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (09) : 544 - 544
  • [50] Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia
    Lew, Jie-Bin
    St John, D. James B.
    Macrae, Finlay A.
    Emery, Jon D.
    Ee, Hooi C.
    Jenkins, Mark A.
    He, Emily
    Grogan, Paul
    Caruana, Michael
    Greuter, Marjolein J. E.
    Coupe, Veerle M. H.
    Canfell, Karen
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (12) : 1450 - 1461